Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS

Seminars in Oncology
Miguel F SanmamedIgnacio Melero

Abstract

T and natural killer (NK) lymphocytes are considered the main effector players in the immune response against tumors. Full activation of T and NK lymphocytes requires the coordinated participation of several surface receptors that meet their cognate ligands through structured transient cell-to-cell interactions known as immune synapses. In the case of T cells, the main route of stimulation is driven by antigens as recognized in the form of short polypeptides associated with major histocompatibility complex (MHC) antigen-presenting molecules. However, the functional outcome of T-cell stimulation towards clonal expansion and effector function acquisition is contingent on the contact of additional surface receptor-ligand pairs and on the actions of cytokines in the milieu. While some of those interactions are inhibitory, others are activating and are collectively termed co-stimulatory receptors. The best studied belong to either the immunoglobulin superfamily or the tumor necrosis factor-receptor (TNFR) family. Co-stimulatory receptors include surface moieties that are constitutively expressed on resting lymphocytes such as CD28 or CD27 and others whose expression is induced upon recent previous antigen priming, ie, CD137, GITR, O...Continue Reading

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B S Kwon, S M Weissman
Aug 1, 1994·The Journal of Experimental Medicine·W R GodfreyE G Engleman
Oct 1, 1996·Immunological Reviews·G WinbergR S Mittler
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·G NocentiniC Riccardi
Jun 10, 1998·The Journal of Experimental Medicine·K SaoulliT H Watts
Jun 10, 1998·International Immunology·H OshimaK Okumura
Dec 18, 2001·Nature Immunology·Janice M KellyMark J Smyth
Apr 3, 2002·Nature Medicine·Zhengmao YeKarl Erik Hellström
Apr 16, 2002·Science·Ruslan Medzhitov, Charles A Janeway
Apr 16, 2002·Science·Polly Matzinger
Jul 18, 2002·Immunity·Kenneth A FrauwirthCraig B Thompson
Oct 16, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ping-Ying PanShu-Hsia Chen
Dec 4, 2003·Nature Reviews. Immunology·Oreste Acuto, Frédérique Michel
Mar 3, 2004·European Journal of Immunology·Simona RonchettiCarlo Riccardi
Mar 5, 2004·Springer Seminars in Immunopathology·Anthony J Coyle, Jose-Carlos Gutierrez-Ramos
Jul 20, 2004·European Journal of Immunology·Ralf BaumannHans-Uwe Simon
Sep 24, 2004·The Journal of Experimental Medicine·Mary Jo TurkAlan N Houghton
Sep 28, 2004·Nature Medicine·Su K SeoByoung S Kwon
May 5, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Roza I Nurieva
May 12, 2005·Current Opinion in Immunology·Jannie BorstYanling Xiao
Jun 28, 2005·Trends in Immunology·Lara M Myers, Anthony T Vella
Apr 4, 2006·Immunology Letters·Miranda E A T van Berkel, Mariëtte A Oosterwegel
Jul 11, 2006·Nature Biotechnology·James O McNamaraPaloma H Giangrande
Aug 16, 2006·The New England Journal of Medicine·Ganesh SuntharalingamNicki Panoskaltsis
Aug 23, 2006·The Journal of Experimental Medicine·Matthias MatterAdrian F Ochsenbein
Oct 26, 2006·Journal of Immunotherapy·Andrew D WeinbergWalter J Urba
Jan 26, 2007·Nature Reviews. Cancer·Ignacio MeleroLieping Chen
Mar 3, 2007·Cancer Research·Yi YangKarl Erik Hellström

❮ Previous
Next ❯

Citations

Sep 15, 2016·Molecular Therapy Oncolytics·Ruslan Novosiadly, Michael Kalos
Nov 28, 2015·Current Problems in Cancer·G Daniel GrassSungjune Kim
Apr 17, 2016·Current Opinion in Immunology·Janine Schuurman, Paul Whi Parren
May 21, 2016·Immunotherapy·Manuela Terranova-BarberioPamela N Munster
Jun 22, 2016·Nature Reviews. Urology·Maria I CarloRobert J Motzer
Jul 28, 2016·Human Vaccines & Immunotherapeutics·William L Redmond, Stefanie N Linch
Jul 19, 2016·Expert Opinion on Biological Therapy·Jiali YangWilliam C Cho
Jul 20, 2016·Immunology and Cell Biology·Ling YiHongtao Zhang
Sep 7, 2016·Vaccines·Saskia J A M SantegoetsSjoerd H van der Burg
Oct 8, 2016·Cancer Immunology, Immunotherapy : CII·Peter EllmarkThomas H Tötterman
Nov 8, 2016·Expert Opinion on Biological Therapy·Panagiotis J VlachostergiosScott T Tagawa
Jan 27, 2017·Journal of Hematology & Oncology·Jun WangZihai Li
Mar 5, 2017·Immunological Reviews·Elizabeth C NowakRandolph J Noelle
Mar 7, 2017·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Frank R Brennan, Andrea Kiessling
Jun 3, 2017·Cell·Taha Merghoub, Jedd D Wolchok
Dec 9, 2016·Proteomics·Frances-Rose SchumacherJennie R Lill
Jun 28, 2017·Immunotherapy·Tomohiro Enokida, Hiroyoshi Nishikawa
Sep 26, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A R Sánchez-PauleteI Melero
Feb 23, 2018·Expert Opinion on Therapeutic Targets·Florent AmatoreDaniel Olive
Feb 9, 2018·The AAPS Journal·Danuta J Herzyk, Helen G Haggerty
Jan 9, 2018·Journal of Immunotherapy·Debra D BloomPeiman Hematti
Dec 7, 2017·Oncoimmunology·Mariona CaboLorenzo Galluzzi
May 31, 2018·International Journal of Molecular Sciences·Riccardo DolcettiVincenzo Canzonieri
May 4, 2018·The Journal of Biological Chemistry·Ryan N GilbrethManuel Baca
Aug 26, 2018·Journal of Cellular Physiology·Hassan Dianat-MoghadamMehdi Yousefi
Jun 19, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kelly A RemediosMichael D Rosenblum
Oct 21, 2017·Cancer Immunology, Immunotherapy : CII·Joseph M ObeidOsama E Rahma
Jan 10, 2020·Science Translational Medicine·Dimitris SkokosGeorge D Yancopoulos
Jul 30, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hyung-Don KimSu-Hyung Park
Apr 26, 2016·The Cancer Journal·Pavlos Msaouel, Erminia Massarelli
Sep 29, 2020·Expert Opinion on Biological Therapy·Victor I Seledtsov, Alexei von Delwig
Jul 27, 2018·Frontiers of Medicine·Fang FangZhigang Tian
Dec 16, 2018·Virchows Archiv : an International Journal of Pathology·Mario Mandalà, Piotr Rutkowski
Jun 12, 2019·International Journal of Molecular Sciences·Wei X HuffMahua Dey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

© 2021 Meta ULC. All rights reserved